Lifestance Health Shares Rise After Q3 Beat, 2024 Revenue Outlook Lifted

MT Newswires Live11-07

Lifestance Health Group (LFST) shares rose 8.7% in early Thursday trading after the company reported Q3 results that topped analyst estimates and raised its 2024 revenue outlook.

The company reported a Q3 net loss of $0.02 per diluted share, compared with a loss of $0.17 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.07.

Revenue for the quarter ended Sept. 30 was $312.7 million, up from $262.9 million a year earlier.

Analysts surveyed by Capital IQ expected $302.3 million.

The company said it expects Q4 revenue of $302.5 million to $322.5 million. Analysts surveyed by Capital IQ expect $311.3 million.

The company said it now expects 2024 revenue of $1.23 billion to $1.25 billion, compared with $1.20 billion to $1.24 billion previously. Analysts polled by Capital IQ expect $1.23 billion.

Price: 7.75, Change: +0.62, Percent Change: +8.70

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment